Elke Nolte

896 total citations
29 papers, 744 citations indexed

About

Elke Nolte is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elke Nolte has authored 29 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elke Nolte's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Genomics and Diagnostics (5 papers). Elke Nolte is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Genomics and Diagnostics (5 papers). Elke Nolte collaborates with scholars based in Germany, Brazil and United States. Elke Nolte's co-authors include Sven Wach, Bernd Wullich, Arndt Hartmann, Friedrich A. Grässer, Jaroslaw Szczyrba, Helge Täubert, Wolf F. Wieland, Robert Stöhr, Bastian Keck and Martin Hart and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Elke Nolte

29 papers receiving 736 citations

Peers

Elke Nolte
Wenwen Du China
Cecil Han United States
Elke Nolte
Citations per year, relative to Elke Nolte Elke Nolte (= 1×) peers Qinghua Liu

Countries citing papers authored by Elke Nolte

Since Specialization
Citations

This map shows the geographic impact of Elke Nolte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Nolte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Nolte more than expected).

Fields of papers citing papers by Elke Nolte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Nolte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Nolte. The network helps show where Elke Nolte may publish in the future.

Co-authorship network of co-authors of Elke Nolte

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Nolte. A scholar is included among the top collaborators of Elke Nolte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Nolte. Elke Nolte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Thill, Marc, Andreé Faridi, Kristin Baumann, et al.. (2020). Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP® Bra): A prospective clinical study in 269 patients. European Journal of Surgical Oncology. 46(8). 1484–1490. 11 indexed citations
3.
Eckstein, Markus, Verena Sailer, Boye Schnack Nielsen, et al.. (2019). Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays. Laboratory Investigation. 99(10). 1527–1534. 13 indexed citations
4.
Wach, Sven, Elke Nolte, Omar Al‐Janabi, et al.. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 16. 272–283. 20 indexed citations
5.
Silva, Izabella Thaís, Jennifer Munkert, Elke Nolte, et al.. (2018). Cytotoxicity of AMANTADIG – a semisynthetic digitoxigenin derivative – alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition. Biomedicine & Pharmacotherapy. 107. 464–474. 12 indexed citations
6.
Bertz, Simone, Elke Nolte, Christine Stöhr, et al.. (2017). Differential prognostic value of MYC immunohistochemistry in subtypes of papillary renal cell carcinoma. Scientific Reports. 7(1). 16424–16424. 6 indexed citations
7.
Szczyrba, Jaroslaw, Volker Jung, Michaela Beitzinger, et al.. (2017). Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes. SHILAP Revista de lepidopterología. 2017. 1–12. 4 indexed citations
8.
Stoehr, Robert, Antonia Wenners, Arndt Hartmann, et al.. (2016). Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis. 5(2). e205–e205. 3 indexed citations
9.
Nolte, Elke, Sven Wach, Tilman T. Rau, et al.. (2016). MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma. PLoS ONE. 11(2). e0148580–e0148580. 15 indexed citations
10.
Täubert, Helge, Sven Wach, Rudolf Jung, et al.. (2015). Piwil 2 Expression Is Correlated with Disease-Specific and Progression-Free Survival of Chemotherapy-Treated Bladder Cancer Patients. Molecular Medicine. 21(1). 371–380. 22 indexed citations
11.
Al‐Janabi, Omar, Sven Wach, Elke Nolte, et al.. (2014). Piwi-like 1 and 4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomas. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(5). 686–690. 26 indexed citations
12.
Al‐Janabi, Omar, Sven Wach, Elke Nolte, et al.. (2014). Abstract 1853: Piwi-like 1 and -4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomas. Cancer Research. 74(19_Supplement). 1853–1853. 1 indexed citations
13.
Hart, Martin, Elke Nolte, Sven Wach, et al.. (2013). Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing. Molecular Cancer Research. 12(2). 250–263. 74 indexed citations
14.
Rogler, Anja, Eileen Socher, Elke Nolte, et al.. (2013). Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.. PubMed. 6(10). 1984–98. 15 indexed citations
15.
Wach, Sven, Elke Nolte, Christine Stöhr, et al.. (2013). MicroRNA profiles classify papillary renal cell carcinoma subtypes. British Journal of Cancer. 109(3). 714–722. 48 indexed citations
16.
Hart, Martin, Sven Wach, Elke Nolte, et al.. (2013). The proto‐oncogeneERGis a target of microRNAmiR‐145in prostate cancer. FEBS Journal. 280(9). 2105–2116. 56 indexed citations
17.
Szczyrba, Jaroslaw, Elke Nolte, Martin Hart, et al.. (2012). Identification of ZNF217, hnRNP‐K, VEGF‐A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma. International Journal of Cancer. 132(4). 775–784. 59 indexed citations
18.
Stoehr, Robert, Elke Nolte, Sven Wach, et al.. (2012). NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians. International Journal of Molecular Sciences. 13(9). 10959–10969. 13 indexed citations
19.
Szczyrba, Jaroslaw, Elke Nolte, Sven Wach, et al.. (2011). Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma. Molecular Cancer Research. 9(6). 791–800. 96 indexed citations
20.
Wach, Sven, Elke Nolte, Jaroslaw Szczyrba, et al.. (2011). MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. International Journal of Cancer. 130(3). 611–621. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026